Biotech
Biotech | 19 July 2026

Cordex expands global access strategy for Zemcelpro

With new distribution agreements in Argentina, Hong Kong & Singapore

Biotech
Biotech | 17 July 2026

Eli Lilly to buy AtaiBeckley in $3.8 billion deal to expand mental health pipeline

Lilly will also gain VLS-01, a buccal film formulation of DMT currently in Phase 2b testing, along with AtaiBeckley's broader pipeline of next-generation neuroplastogens aimed at restoring the brain's ability to form new neural connections

Biotech
Biotech | 23 June 2026

Suven Life Sciences to spotlight CNS pipeline & strike partnering deals at BIO-2026 San Diego

The company plans an aggressive partnering push, with 62 pre-scheduled meetings over four days, focused on out-licensing, co-development, and strategic collaborations with global pharmaceutical and biotech players

Biotech
Biotech | 19 June 2026

Brooks Instrument launches ultra-compact advanced mass flow controller for research applications

New AMF Series combines industry-leading 1000:1 turndown capability, predictive diagnostics, and digital connectivity in a footprint no larger than a standard Post-it Note pad

Biotech
Biotech | 10 June 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities

Biotech
Biotech | 26 May 2026

Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision

AAV vectors are widely used in gene therapy for their strong therapeutic potential

Biotech
Biotech | 25 May 2026

Enveric reports key safety milestone for EB-003 reinforcing clinical development path

The findings support the continued advancement of EB-003, a first-in-class neuroplastogen designed to selectively target both 5-HT2A and 5-HT1B receptors

Biotech
Biotech | 19 May 2026

NunaBio secures £6.5 million to scale DNA manufacturing platform

Funding to accelerate development of integrated DNA platform supporting vaccines, gene therapies and advanced biologics

Biotech
Biotech | 19 May 2026

OrganaBio expands cell therapy manufacturing footprint with acquisition of Excellos Assets

The deal also establishes a new subsidiary, Excellos Labs, which will oversee continued operations in San Diego

Biotech
Biotech | 15 May 2026

Telangana life sciences ecosystem reaches $145 billion valuation

The state has received Rs. 84,000 crore investments in the sector over two years, positioning Hyderabad among the world’s leading life sciences clusters

Biotech
Biotech | 08 May 2026

MilliporeSigma lands exclusive 5-year deal to test Genetix Biotherapeutics gene therapies

The deal positions MilliporeSigma at the center of commercial manufacturing for three breakthrough gene therapies targeting sickle cell disease, ?-thalassemia, and cerebral adrenoleukodystrophy

Biotech
Biotech | 29 April 2026

Leinco Technologies and CellCarta partner to advance proteomics in immuno-oncology

The combined offering is designed to support a wide range of applications, from pilot-scale research to high-volume clinical use

Biotech
Biotech | 23 April 2026

Evonik bets €80 million on biotech expansion to power next-gen pharma growth

The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances

Biotech
Biotech | 21 April 2026

BioMed X launches AI-driven bispecific antibody research team in France

The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation

Biotech
Biotech | 20 April 2026

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols

Biotech
Biotech | 20 April 2026

FDA pushes forward on gene-editing therapies with new safety roadmap

Genome editing holds extraordinary promise for treating previously incurable genetic diseases

Biotech
Biotech | 20 April 2026

Precision BioSciences expands Hepatitis B gene editing trial into France and Romania

The Clinical Trial Application (CTA) approval clears the way for the company to launch trial locations in France and Romania

Biotech
Biotech | 18 April 2026

Department of Biotechnology invites applications for DBT Research Associateship 2025–26

Postdoctoral fellowship aims to build skilled talent pool in biotechnology and life sciences

Startup

Digitization